We suggest that the CD4/CD8 cell ratio (or IHGs) can be utilized to gain insight into anticipated complications related to a patient’s immunodeficiency by using more well-understood monogenetic diseases with similar CD4/CD8 cell ratios as a guide. This evidence concerns the gene CD8A and immunodeficiency disease.